Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_assertion description "[PF00299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_assertion evidence source_evidence_literature NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_assertion SIO_000772 18089823 NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_assertion wasDerivedFrom lhgdn-20090331 NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_assertion wasGeneratedBy ECO_0000203 NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.